Opioid-sparing Effect of Intranasal Dexmedetomidine
NCT05848505
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Tonsillar Hypertrophy
Interventions
DRUG:
Dexmedetomidine
Sponsor
Pierre-Yves P Lequeux